Merck buys Ireland vaccines plant from troubled WuXi for €500M
Jan 6, 2025 · With potential passage of the BIOSECURE Act looming, WuXi Biologics has sold a new vaccines plant in Ireland to Merck & Co. for €500 million ($521 million).
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
Jan 6, 2025 · Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million. The two companies have been collaborating on the Dundalk …
Merck to buy WuXi Biologics' Irish vaccine facility for $500 million
Jan 7, 2025 · WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland to MSD International, a subsidiary of Merck & …
China's WuXi Biologics to sell Irish vaccine facility to Merck as US ...
Jan 6, 2025 · China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million, ahead of potential U.S. legislation that …
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in …
Jan 16, 2025 · A subsidiary of the Chinese contract development and manufacturing organization (CDMO), WuXi Vaccines, will sell its vaccine manufacturing facility in Dundalk, Ireland to …
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Jan 7, 2025 · WuXi Biologics has announced the sale of its Dundalk, Ireland-based vaccine manufacturing facility to Merck for US$500 million. This news comes shortly after its parent …
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over …
Jan 7, 2025 · On Monday, Merck & Co Inc (NYSE: MRK) announced the acquisition of WuXi Vaccines‘ manufacturing site in Dundalk, Co Louth, marking a significant expansion of its …
WuXi Biologics to Sell Irish Facility to Merck for $500M
Jan 7, 2025 · WuXi Biologics, through its subsidiary WuXi Vaccines, has agreed to sell its manufacturing facility in Dundalk, Ireland, to Merck for $500 million. The deal is expected to …
WuXi Biologics to Sell Irish Vaccine Facility to Merck
Jan 7, 2025 · The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday.
China’s WuXi Biologics sells Irish vaccine facility to Merck for $500M
Jan 6, 2025 · Chinese CDMO WuXi Biologics is selling its vaccine manufacturing facility in Dundalk, Ireland, for approximately $500 million to Merck, known as MSD outside of the U.S. …